Forian Inc.FORAEarnings & Financial Report
Forian Inc is a specialized healthcare technology and data analytics firm offering SaaS-based real-world evidence solutions, clinical decision support tools, and operational optimization services. It serves biopharmaceutical companies, healthcare providers, and life sciences stakeholders to improve patient outcomes, accelerate research, and boost care delivery efficiency.
Revenue
$4.9M
Gross Profit
$3.2M
Operating Profit
$-1.8M
Net Profit
$-1.2M
Gross Margin
65.1%
Operating Margin
-36.3%
Net Margin
-24.9%
YoY Growth
-3.9%
EPS
$-0.04
Forian Inc. Q1 FY2024 Financial Summary
Forian Inc. reported revenue of $4.9M (down 3.9% YoY) for Q1 FY2024, with a net profit of $-1.2M (down 118.1% YoY) (-24.9% margin). Cost of goods sold was $1.7M, operating expenses totaled $4.9M.
Key Financial Metrics
| Total Revenue | $4.9M |
|---|---|
| Net Profit | $-1.2M |
| Gross Margin | 65.1% |
| Operating Margin | -36.3% |
| Report Period | Q1 FY2024 |
Forian Inc. Annual Revenue by Year
Forian Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $30.3M).
| Year | Annual Revenue |
|---|---|
| 2025 | $30.3M |
| 2024 | $20.2M |
| 2023 | $21.2M |
| 2022 | $16.4M |
Forian Inc. Quarterly Revenue & Net Profit History
Forian Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $8.0M | +37.0% | $-1.8M | -22.9% |
| Q3 FY2025 | $7.8M | +65.6% | $-151.2K | -1.9% |
| Q2 FY2025 | $7.5M | +56.5% | $224.8K | 3.0% |
| Q1 FY2025 | $7.1M | +44.7% | $-1.1M | -16.0% |
| Q4 FY2024 | $5.8M | +5.5% | $199.7K | 3.4% |
| Q3 FY2024 | $4.7M | -15.3% | $-204.9K | -4.4% |
| Q2 FY2024 | $4.8M | -6.3% | $-2.6M | -53.4% |
| Q1 FY2024 | $4.9M | -3.9% | $-1.2M | -24.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9M | $4.8M | $4.7M | $5.8M | $7.1M | $7.5M | $7.8M | $8.0M |
| YoY Growth | -3.9% | -6.3% | -15.3% | 5.5% | 44.7% | 56.5% | 65.6% | 37.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $57.5M | $58.4M | $57.5M | $47.2M | $48.6M | $48.5M | $41.3M | $44.1M |
| Liabilities | $31.0M | $32.7M | $30.6M | $17.1M | $18.6M | $17.5M | $10.2M | $14.4M |
| Equity | $28.1M | $27.2M | $28.4M | $30.1M | $30.0M | $30.9M | $31.1M | $29.8M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.2M | $-23110 | $764096 | $1.7M | $448180 | $-344531 | $-439666 | $3.2M |